BioLine definition
BioLine s Manufacturer” shall mean [***], [***] or any other manufacturer engaged by BioLine to manufacture and supply the Licensed Product as agreed by the Licensee.
BioLine shall have the meaning given to it in the Preamble.
BioLine shall have the meaning given in the preamble of this Agreement. 1.1.7 “Business Day” means any day other than a Friday, Saturday, Sunday, or other day on which commercial banks in Norway or the State of Israel are required or authorized by Applicable Law to be closed, at any time between 9:00 a.m. and 5:00 p.m. in the time zone of the relevant jurisdiction. 1.1.8 “Business Information” means business information owned by, held by or under the control of Hemispherian and/or its Affiliates at the Asset Transfer Closing in relation to the Lead Compound and the Secondary Compound consisting of (i) vendor/supplier lists, sales, marketing and promotional information; and (ii) market surveys, business plans and forecasts; all as set forth in the Virtual Data Room. 1.1.9 “Claim” shall have the meaning given to it in Section 6.3.1. 1.1.10 “Closing Conditions” shall have the meaning given to it in Section 8.1. 1.1.11 “Company” shall have the meaning given in the preamble of this Agreement. 1.1.12 “Compliance Confirmation” shall have the meaning given to it in Section 8.1. 1.1.13 “Compounds” means all the Lead Compound, the Secondary Compound and the Other Compounds. 1.1.14 “Designated Chairpersons” shall have the meaning given to it in Section 11. 1.1.15 “Dispute” shall have the meaning given to it in Section 11. 1.1.16 “DVD ROM” means the read only memory disk produced by Hemispherian which contains a copy of all the documents and materials uploaded to the Virtual Data Room as of the Asset Transfer Closing Date. 1.1.17 “Encumbrance” means with respect to any security, property or asset, as the case may be, any mortgage, lien, pledge, charge, security interest, encumbrance, hypothecation, option, easement, trust, equitable interest, proxies, right of first refusal, defect in title, impediment of title, impairment of title, preemptive right or restrictions or rights of third parties of any nature (including any spousal community property rights, any restriction on the voting, transfer, receipt of any income derived from, the possession of any security, or the exercise or transfer of any other attribute of ownership of a security). 1.1.18 “Excluded Liabilities” means the Liabilities relating to the Transferred Assets and outstanding or accrued or referable to the period on or before the Asset Transfer Closing Date or arising by virtue of the transfer of the Transferred Assets recorded by this Agreement, including (i) the Liabilities to creditors of Hemispherian includ...
More Definitions of BioLine
BioLine means BioLineRx Ltd., as further defined in the Preamble above. “Change of Control” means a transaction which results in a change in the power to direct (directly or indirectly) the management and policies of BioLine through the ownership of voting capital, by which (i) any person or group becomes the beneficial owner of voting securities (including any options, rights or warrants to purchase, and any securities convertible into or exchangeable for, voting securities) of BioLine representing 50% or more of the voting power represented by all outstanding securities of BioLine; or (ii) a majority of the seats on the board of directors of BioLine shall at any time be occupied by persons who were not members of the board of directors prior to such transaction. “Clinical Proof of Concept” means the conclusion of the first clinical study in healthy human volunteers or patients showing safety, tolerability, pharmacodynamic activity, pharmacokinetics, early evidence of efficacy, generally equivalent to a Phase I study pursuant to FDA regulations or foreign equivalents, as well as evidence of drug metabolism and mechanism of action, all as specifically agreed by the Parties during the process of establishing the Core Terms. “Closing Price Per ADS” has the meaning set out in Section 2.1. “Collaboration” has the meaning set out in the Preamble above. “Collaboration Quota” means the presentation by BioLine to NVS at the Joint Steering Committee of seven projects, each of which is either: (a) an IND Project; or (b) a Pre-IND Project with respect to which NVS has exercised Matching Rights, where such project has been sublicensed by BioLine to NVS pursuant to the arrangements set out in Section 5.2.5. “Confidential Information” means, with respect to a Party, all reports and other Information of such Party that is disclosed to the other Party pursuant to the arrangements set out in this Agreement, whether in oral, written, graphic, or electronic form. All Information disclosed by a Party pursuant to the Mutual Non-Disclosure Agreement between the Parties dated May 7, 2014, as amended through the Effective Date, shall be deemed to be such Party’s Confidential Information disclosed hereunder. “Core Term Memorandum” has the meaning set out in Section 6.3.3. “Core Terms” has the meaning set out in Section 6.3. “CSR” has the meaning set out in Section 6.8. “Development Budget Balance” has the meaning set out in Section 6.5.1. “Dollar” means the U.S. dollar, and “$” shall be i...
BioLine s Manufacturing Cost” shall mean, with respect to any Licensed Product, if such Licensed Product (or any precursor or intermediate thereof) is Manufactured or have-Manufactured by BioLine or its Affiliates, the price charged by BioLine’s Manufacturer as proved by the invoice issued by BioLine’s Manufacturer to BioLine multiplied by [***]%.
BioLine means BioLineRx Ltd., as further defined in the Preamble above.